ALISON GIESE: Open Payments
NPI 1861860561 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 15 payments from 14 companies in 2025. Trend: 2023 $278 · 2024 $1,364 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc | 1 | $100 |
| ABBVIE INC. | 2 | $58 |
| GENZYME CORPORATION | 1 | $41 |
| Adaptive Biotechnologies Corporation | 1 | $37 |
| PharmaEssentia USA Corporation | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| TAIHO ONCOLOGY, INC. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
Products named: XT CDX, SARCLISA, clonoSEQ, IMBRUVICA, ELAHERE, BESREMI, KEYTRUDA, LONSURF.
Industry payments across OH — which companies pay providers there.
